Does FLUVOXAMINE MALEATE Interact with other Medications?

Severe Interactions

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SEROTONIN REUPTAKE INHIBITORS; SNRIS/SELECTED MAOIS
  • FLUVOXAMINE/CISAPRIDE
  • STRONG & MODERATE CYP2C19 INHIBITORS/MAVACAMTEN
  • SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (> 50MG)
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>40MG)
  • SEROTONINERGIC AGENTS/DAPOXETINE
  • FLUVOXAMINE/AGOMELATINE
  • FLUVOXAMINE/RAMELTEON
  • FLUVOXAMINE/TIZANIDINE
  • FLUVOXAMINE/ALOSETRON
  • SELECTED SSRIS; DULOXETINE/THIORIDAZINE
  • SSRIS; NEFAZODONE/PIMOZIDE
  • SEROTONINERGIC AGENTS/SIBUTRAMINE
  • SEROTONINERGIC AGENTS/DEXFENFLURAMINE; FENFLURAMINE
  • SSRIS; NEFAZODONE/ASTEMIZOLE; TERFENADINE
  • Serious Interactions

    These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SEROTONIN REUPTAKE INHIBITORS/LINEZOLID
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
  • DUAL WEAK CYP2D6 AND CYP3A4 INHIBITORS/ELIGLUSTAT
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
  • P-GP INHIBITORS THAT CAUSE BLEEDING/BETRIXABAN; DABIGATRAN
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
  • WEAK CYP3A4 INHIBITORS/LONAFARNIB
  • MODERATE CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
  • P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
  • DUAL INHIBITORS OF CYP2C19 & CYP3A4/FEDRATINIB
  • MODERATE CYP3A4 INHIBITORS/BRIGATINIB
  • AGENTS THAT AFFECT CATECHOLAMINES/IOBENGUANE I 123
  • AGENTS THAT AFFECT CATECHOLAMINES/IOBENGUANE I 131
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30MG OR <=40MG)
  • FLUVOXAMINE/SELECTED BENZODIAZEPINES
  • STRONG CYP1A2 INHIBITORS/TASIMELTEON
  • CIPROFLOXACIN; FLUVOXAMINE/OLANZAPINE EXTENDED RELEASE IM
  • STRONG CYP1A2 INHIBITORS/PIRFENIDONE
  • STRONG; SELECTED MODERATE CYP2C19 INHIBITORS/CLOBAZAM
  • FLUVOXAMINE/HYDANTOINS
  • CLOMIPRAMINE; IMIPRAMINE; SSRIS; SNRIS;/MEPERIDINE
  • FLUVOXAMINE/CLOZAPINE
  • SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
  • DOPAMINE TRANSPORTER BINDERS/IOFLUPANE I 123
  • FLUOXETINE; FLUVOXAMINE/CLOPIDOGREL
  • SSRIS; SNRIS/METOCLOPRAMIDE
  • STRONG CYP1A2 INHIBITORS/DULOXETINE
  • SSRIS; SNRIS/SELECTED ANTICOAGULANTS (VITAMIN K ANTAGONISTS)
  • Moderate Interactions

    These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • DULOXETINE; FLUVOXAMINE/SELECTED TRICYCLIC COMPOUNDS
  • SSRIS; SNRIS/SELECTED NSAIDS; ASPIRIN
  • SELECT SEROTONERGIC AGENTS/FENTANYL
  • SELECTED SSRIS; SNRIS/CYCLOBENZAPRINE
  • SELECTED SSRIS; SNRIS/TRAZODONE
  • SSRIS; VILAZODONE/FLURBIPROFEN
  • SSRIS; VILAZODONE/SELECTED NSAIDS
  • SELECTED SSRIS;SNRIS/CILOSTAZOL; TICLOPIDINE
  • SELECTED STRONG CYP2C19 INHIBITORS/ABROCITINIB
  • SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
  • STRONG CYP1A2 INHIBITORS/BROMAZEPAM
  • STRONG CYP2C19 INHIBITORS/BELZUTIFAN
  • FLUVOXAMINE/SLT ANTICOAGULANTS;ANTIPLATELETS;THROMBOLYTICS
  • P-GP INHIBITORS THAT CAUSE BLEEDING/EDOXABAN (<=30 MG)
  • P-GP INHIBITORS THAT CAUSE BLEEDING/EDOXABAN (>30 MG)
  • FLUVOXAMINE/PROPRANOLOL
  • WEAK CYP3A4 INHIBITORS/UBROGEPANT
  • WEAK CYP3A4 INHIBITORS/LEMBOREXANT
  • SELECTED SSRIS; SNRIS/TRAMADOL
  • WEAK CYP3A4 INHIBITORS/TACROLIMUS
  • MODERATE CYP3A4 INHIBITORS/ZANUBRUTINIB
  • SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (<=50MG)
  • SNRIS; SSRIS/BUPROPION
  • AGENTS WITH HYPONATREMIA RISK/DESMOPRESSIN
  • SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
  • AGENTS WITH HYPONATREMIA RISK/DESMOPRESSIN (NOCTURIA)
  • FLUVOXAMINE/LIDOCAINE
  • STRONG CYP1A2 INHIBITORS/ROPIVACAINE
  • SELECTED STRONG CYP2C19 INHIBITORS/FLIBANSERIN
  • MODERATE CYP3A4 INHIBITORS/IBRUTINIB
  • STRONG CYP1A2 INHIBITORS/POMALIDOMIDE
  • SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
  • WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
  • FLUOXETINE; FLUVOXAMINE/HALOPERIDOL
  • SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
  • SELECTED P-GP AND WEAK CYP3A4 INHIBITORS/RIVAROXABAN
  • FLUVOXAMINE/TACRINE
  • SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
  • CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
  • FLUVOXAMINE/OLANZAPINE
  • SSRIS; SNRIS/AMPHETAMINES; PHENTERMINE
  • SSRIS; SNRIS/LITHIUM
  • FLUVOXAMINE/SELECTED XANTHINE DERIVATIVES
  • SSRIS; SNRIS/TAPENTADOL
  • FLUVOXAMINE/LEVOMETHADONE; METHADONE
  • SELECTED SSRIS/CARBAMAZEPINE
  • Free RX Coupon

    Save up to 80% on your prescriptions.

    Available coupons

    Save up to 80% on your prescription with WebMDRx

    Drug Survey

    Are you currently using fluvoxamine MALEATE?

    This survey is being conducted by the WebMD marketing sciences department.

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.